wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37692633-CF5E7217-64F5-487C-8F09-CB58D531EA40
Q37692633-CF5E7217-64F5-487C-8F09-CB58D531EA40
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37692633-CF5E7217-64F5-487C-8F09-CB58D531EA40
Recommendations from the European Working Group for Value Assessment and Funding Processes in Rare Diseases (ORPH-VAL).
P2860
Q37692633-CF5E7217-64F5-487C-8F09-CB58D531EA40
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37692633-CF5E7217-64F5-487C-8F09-CB58D531EA40
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3ec6f2475f1a5c7f266cff979f1bed1188ae995d
P2860
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS).